- IBDEI2KM ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,41031,1,4,0)
- ;;=4^A81.9
- ;;^UTILITY(U,$J,358.3,41031,2)
- ;;=^5000414
- ;;^UTILITY(U,$J,358.3,41032,0)
- ;;=A81.09^^152^2020^8
- ;;^UTILITY(U,$J,358.3,41032,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41032,1,3,0)
- ;;=3^Creutzfeldt-Jakob Disease NEC
- ;;^UTILITY(U,$J,358.3,41032,1,4,0)
- ;;=4^A81.09
- ;;^UTILITY(U,$J,358.3,41032,2)
- ;;=^5000410
- ;;^UTILITY(U,$J,358.3,41033,0)
- ;;=A81.00^^152^2020^9
- ;;^UTILITY(U,$J,358.3,41033,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41033,1,3,0)
- ;;=3^Creutzfeldt-Jakob Disease,Unspec
- ;;^UTILITY(U,$J,358.3,41033,1,4,0)
- ;;=4^A81.00
- ;;^UTILITY(U,$J,358.3,41033,2)
- ;;=^5000409
- ;;^UTILITY(U,$J,358.3,41034,0)
- ;;=A81.01^^152^2020^10
- ;;^UTILITY(U,$J,358.3,41034,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41034,1,3,0)
- ;;=3^Creutzfeldt-Jakob Disease,Variant
- ;;^UTILITY(U,$J,358.3,41034,1,4,0)
- ;;=4^A81.01
- ;;^UTILITY(U,$J,358.3,41034,2)
- ;;=^336701
- ;;^UTILITY(U,$J,358.3,41035,0)
- ;;=A81.89^^152^2020^7
- ;;^UTILITY(U,$J,358.3,41035,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41035,1,3,0)
- ;;=3^Atypical Virus Infections of CNS NEC
- ;;^UTILITY(U,$J,358.3,41035,1,4,0)
- ;;=4^A81.89
- ;;^UTILITY(U,$J,358.3,41035,2)
- ;;=^5000413
- ;;^UTILITY(U,$J,358.3,41036,0)
- ;;=A81.2^^152^2020^27
- ;;^UTILITY(U,$J,358.3,41036,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41036,1,3,0)
- ;;=3^Progressive Multifocal Leukoencephalopathy
- ;;^UTILITY(U,$J,358.3,41036,1,4,0)
- ;;=4^A81.2
- ;;^UTILITY(U,$J,358.3,41036,2)
- ;;=^5000411
- ;;^UTILITY(U,$J,358.3,41037,0)
- ;;=B20.^^152^2020^17
- ;;^UTILITY(U,$J,358.3,41037,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41037,1,3,0)
- ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
- ;;^UTILITY(U,$J,358.3,41037,1,4,0)
- ;;=4^B20.
- ;;^UTILITY(U,$J,358.3,41037,2)
- ;;=^5000555^F02.81
- ;;^UTILITY(U,$J,358.3,41038,0)
- ;;=B20.^^152^2020^18
- ;;^UTILITY(U,$J,358.3,41038,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41038,1,3,0)
- ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
- ;;^UTILITY(U,$J,358.3,41038,1,4,0)
- ;;=4^B20.
- ;;^UTILITY(U,$J,358.3,41038,2)
- ;;=^5000555^F02.80
- ;;^UTILITY(U,$J,358.3,41039,0)
- ;;=F10.27^^152^2020^1
- ;;^UTILITY(U,$J,358.3,41039,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41039,1,3,0)
- ;;=3^Alcohol Dependence w/ Alcohol-Induced Persisting Dementia
- ;;^UTILITY(U,$J,358.3,41039,1,4,0)
- ;;=4^F10.27
- ;;^UTILITY(U,$J,358.3,41039,2)
- ;;=^5003095
- ;;^UTILITY(U,$J,358.3,41040,0)
- ;;=F19.97^^152^2020^29
- ;;^UTILITY(U,$J,358.3,41040,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41040,1,3,0)
- ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
- ;;^UTILITY(U,$J,358.3,41040,1,4,0)
- ;;=4^F19.97
- ;;^UTILITY(U,$J,358.3,41040,2)
- ;;=^5003465
- ;;^UTILITY(U,$J,358.3,41041,0)
- ;;=F03.90^^152^2020^15
- ;;^UTILITY(U,$J,358.3,41041,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41041,1,3,0)
- ;;=3^Dementia w/o Behavioral Disturbance,Unspec
- ;;^UTILITY(U,$J,358.3,41041,1,4,0)
- ;;=4^F03.90
- ;;^UTILITY(U,$J,358.3,41041,2)
- ;;=^5003050
- ;;^UTILITY(U,$J,358.3,41042,0)
- ;;=G30.0^^152^2020^2
- ;;^UTILITY(U,$J,358.3,41042,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41042,1,3,0)
- ;;=3^Alzheimer's Disease w/ Early Onset
- ;;^UTILITY(U,$J,358.3,41042,1,4,0)
- ;;=4^G30.0
- ;;^UTILITY(U,$J,358.3,41042,2)
- ;;=^5003805
- ;;^UTILITY(U,$J,358.3,41043,0)
- ;;=G30.1^^152^2020^3
- ;;^UTILITY(U,$J,358.3,41043,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41043,1,3,0)
- ;;=3^Alzheimer's Disease w/ Late Onset
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2KM 3801 printed Feb 18, 2025@23:57:01 Page 2
- IBDEI2KM ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,41031,1,4,0)
- +2 ;;=4^A81.9
- +3 ;;^UTILITY(U,$J,358.3,41031,2)
- +4 ;;=^5000414
- +5 ;;^UTILITY(U,$J,358.3,41032,0)
- +6 ;;=A81.09^^152^2020^8
- +7 ;;^UTILITY(U,$J,358.3,41032,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,41032,1,3,0)
- +10 ;;=3^Creutzfeldt-Jakob Disease NEC
- +11 ;;^UTILITY(U,$J,358.3,41032,1,4,0)
- +12 ;;=4^A81.09
- +13 ;;^UTILITY(U,$J,358.3,41032,2)
- +14 ;;=^5000410
- +15 ;;^UTILITY(U,$J,358.3,41033,0)
- +16 ;;=A81.00^^152^2020^9
- +17 ;;^UTILITY(U,$J,358.3,41033,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,41033,1,3,0)
- +20 ;;=3^Creutzfeldt-Jakob Disease,Unspec
- +21 ;;^UTILITY(U,$J,358.3,41033,1,4,0)
- +22 ;;=4^A81.00
- +23 ;;^UTILITY(U,$J,358.3,41033,2)
- +24 ;;=^5000409
- +25 ;;^UTILITY(U,$J,358.3,41034,0)
- +26 ;;=A81.01^^152^2020^10
- +27 ;;^UTILITY(U,$J,358.3,41034,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,41034,1,3,0)
- +30 ;;=3^Creutzfeldt-Jakob Disease,Variant
- +31 ;;^UTILITY(U,$J,358.3,41034,1,4,0)
- +32 ;;=4^A81.01
- +33 ;;^UTILITY(U,$J,358.3,41034,2)
- +34 ;;=^336701
- +35 ;;^UTILITY(U,$J,358.3,41035,0)
- +36 ;;=A81.89^^152^2020^7
- +37 ;;^UTILITY(U,$J,358.3,41035,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,41035,1,3,0)
- +40 ;;=3^Atypical Virus Infections of CNS NEC
- +41 ;;^UTILITY(U,$J,358.3,41035,1,4,0)
- +42 ;;=4^A81.89
- +43 ;;^UTILITY(U,$J,358.3,41035,2)
- +44 ;;=^5000413
- +45 ;;^UTILITY(U,$J,358.3,41036,0)
- +46 ;;=A81.2^^152^2020^27
- +47 ;;^UTILITY(U,$J,358.3,41036,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,41036,1,3,0)
- +50 ;;=3^Progressive Multifocal Leukoencephalopathy
- +51 ;;^UTILITY(U,$J,358.3,41036,1,4,0)
- +52 ;;=4^A81.2
- +53 ;;^UTILITY(U,$J,358.3,41036,2)
- +54 ;;=^5000411
- +55 ;;^UTILITY(U,$J,358.3,41037,0)
- +56 ;;=B20.^^152^2020^17
- +57 ;;^UTILITY(U,$J,358.3,41037,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,41037,1,3,0)
- +60 ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
- +61 ;;^UTILITY(U,$J,358.3,41037,1,4,0)
- +62 ;;=4^B20.
- +63 ;;^UTILITY(U,$J,358.3,41037,2)
- +64 ;;=^5000555^F02.81
- +65 ;;^UTILITY(U,$J,358.3,41038,0)
- +66 ;;=B20.^^152^2020^18
- +67 ;;^UTILITY(U,$J,358.3,41038,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,41038,1,3,0)
- +70 ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
- +71 ;;^UTILITY(U,$J,358.3,41038,1,4,0)
- +72 ;;=4^B20.
- +73 ;;^UTILITY(U,$J,358.3,41038,2)
- +74 ;;=^5000555^F02.80
- +75 ;;^UTILITY(U,$J,358.3,41039,0)
- +76 ;;=F10.27^^152^2020^1
- +77 ;;^UTILITY(U,$J,358.3,41039,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,41039,1,3,0)
- +80 ;;=3^Alcohol Dependence w/ Alcohol-Induced Persisting Dementia
- +81 ;;^UTILITY(U,$J,358.3,41039,1,4,0)
- +82 ;;=4^F10.27
- +83 ;;^UTILITY(U,$J,358.3,41039,2)
- +84 ;;=^5003095
- +85 ;;^UTILITY(U,$J,358.3,41040,0)
- +86 ;;=F19.97^^152^2020^29
- +87 ;;^UTILITY(U,$J,358.3,41040,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,41040,1,3,0)
- +90 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
- +91 ;;^UTILITY(U,$J,358.3,41040,1,4,0)
- +92 ;;=4^F19.97
- +93 ;;^UTILITY(U,$J,358.3,41040,2)
- +94 ;;=^5003465
- +95 ;;^UTILITY(U,$J,358.3,41041,0)
- +96 ;;=F03.90^^152^2020^15
- +97 ;;^UTILITY(U,$J,358.3,41041,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,41041,1,3,0)
- +100 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
- +101 ;;^UTILITY(U,$J,358.3,41041,1,4,0)
- +102 ;;=4^F03.90
- +103 ;;^UTILITY(U,$J,358.3,41041,2)
- +104 ;;=^5003050
- +105 ;;^UTILITY(U,$J,358.3,41042,0)
- +106 ;;=G30.0^^152^2020^2
- +107 ;;^UTILITY(U,$J,358.3,41042,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,41042,1,3,0)
- +110 ;;=3^Alzheimer's Disease w/ Early Onset
- +111 ;;^UTILITY(U,$J,358.3,41042,1,4,0)
- +112 ;;=4^G30.0
- +113 ;;^UTILITY(U,$J,358.3,41042,2)
- +114 ;;=^5003805
- +115 ;;^UTILITY(U,$J,358.3,41043,0)
- +116 ;;=G30.1^^152^2020^3
- +117 ;;^UTILITY(U,$J,358.3,41043,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,41043,1,3,0)
- +120 ;;=3^Alzheimer's Disease w/ Late Onset
